Jacob Karr, MD
Gastroenterology · Lafayette, LANPI 1790919173
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,971 of the $10,307 with a category attached, or 67.6%. 31 manufacturers reported payments, led by Olympus Corporation at 31.6% of the total. Reporting peaked in 2023 at $2,739 and has fallen 60.6% since, to $1,078 in 2025.
Across 478 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation$3K
- AbbVie$2K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$568
- Bristol Myers Squibb$505
- Pfizer$419
- plus $2K from 25 others
Across 109 payments — averaging $1571.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$119K
- Janssen Research & Development, LLC$52K
What the payments were for
- Consulting fees$1,99519%
- Speaking & faculty fees$1,26012%
- Food & beverage$6,97168%
- Education$811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation | 7 | $3,255 |
| AbbVie(2 entities) | 188 | $2,445 |
| Johnson & Johnson(2 entities) | 75 | $1,086 |
| Takeda Pharmaceuticals U.S.A., Inc. | 37 | $568 |
| Bristol Myers Squibb | 34 | $505 |
| Pfizer | 28 | $419 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $381 |
| Gilead | 22 | $324 |
| Boston Scientific | 4 | $153 |
| Intercept Pharmaceuticals, Inc. | 3 | $146 |
| Medtronic | 3 | $137 |
| Janssen Scientific Affairs, LLC | 1 | $120 |
| Daiichi Sankyo Inc. | 5 | $106 |
| Ardelyx, Inc. | 5 | $87 |
| Phathom Pharmaceuticals, Inc. | 8 | $72 |
| Nestle Healthcare Nutrition Inc. | 5 | $70 |
| Ferring Pharmaceuticals Inc. | 4 | $70 |
| Merck | 4 | $50 |
| Braintree Laboratories, Inc. | 3 | $47 |
| UCB, Inc. | 3 | $43 |
| Redhill Biopharma Inc. | 3 | $40 |
| Sanofi | 2 | $37 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Conmed Corporation | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $17 |
| Madrigal Pharmaceuticals | 1 | $16 |
| Enterra Medical, Inc. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Olympus America Inc. | 1 | $15 |
| Amgen | 1 | $13 |
| Phadia US Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$130
- GI Genius$125
- OCALIVA$122
- STELARA$120
- EXALT MODEL D CONTROLLER$104
How this compares
$10,307 in reported general payments places this provider in the 80th percentile of 254 gastroenterology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 18 | $477,124 |
| LinzessLinaclotide | 76 | $50,177 |
| VoqueznaVonoprazan Fumarate | 59 | $41,893 |
| IbsrelaTenapanor Hcl | 32 | $40,622 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 233 | $15,258 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 78 | $13,207 |
| Pantoprazole Sodium | 1,041 | $12,363 |
| TrulancePlecanatide | 22 | $12,207 |
| Dexlansoprazole DrDexlansoprazole | 59 | $10,728 |
| MovantikNaloxegol Oxalate | 20 | $10,259 |
| Mesalamine | 11 | $7,256 |
| Sucralfate | 84 | $4,955 |
| MotegrityPrucalopride Succinate | 17 | $4,422 |
| Esomeprazole Magnesium | 77 | $2,186 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 13 | $2,103 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $1,086 | $477,12418 claims |
| AbbVieLinzess | $2,445 | $50,17776 claims |
| Phathom Pharmaceuticals, Inc.Voquezna | $72 | $41,89359 claims |
| Ardelyx, Inc.Ibsrela | $87 | $40,62232 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $70 | $13,20778 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $381 | $12,20722 claims |
| Redhill Biopharma Inc.Movantik | $40 | $10,25920 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $568 | $4,42217 claims |
| Braintree Laboratories, Inc.Sutab, Suflave | $47 | $3,45224 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 254 gastroenterology providers in Louisiana.
Other gastroenterology in Lafayette
- Eric TrawickLafayette$54K
- Erick SalvatierraLafayette$27K
- Jacque NoelLafayette$12K
- Jacob BreauxLafayette$9K
- Jonathon ChapmanBaton Rouge$998K
- Conar FittonKenner$955K
- Gia LandryBaton Rouge$511K
- Charles MonierThibodaux$448K
- Nathaniel RanneyCovington$392K
- Georges CatinisMetairie$346K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.